1.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7841
|
|
2.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-1583
|
|
3.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCCTG-825251, NCCTG-82-52-51
|
|
4.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 70
Sponsor: NCI
Protocol IDs: SWOG-8040
|
|
5.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-1285
|
|
6.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 70 and under
Sponsor:
Protocol IDs: EORTC-40851
|
|
7.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: FCCC-85719, NCI-V85-0077
|
|
8.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 85 and under
Sponsor:
Protocol IDs: EORTC-30864
|
|
9.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2277
|
|
10.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-3274, MAYO-706018
|
|
11.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: GITSG-8375
|
|
12.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: GITSG-8376, MAYO-764101
|
|
13.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: GITSG-8376R
|
|
14.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: Other
Protocol IDs: EORTC-22011, EORTC-40014, NCT00068744
|
|
15.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: AG0501CR, NCT00294359
|
|
16.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: Other
Protocol IDs: URO-DW-1971, NCT00816075
|
|
17.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 75
Sponsor:
Protocol IDs: FRE-FNCLCC-CO-II, NCI-F94-0020
|
|
18.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: MRC-BS03, EU-94007
|
|
19.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MRC-BS07, EU-94028
|
|
20.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: SWS-SAKK-40/93, EU-94038
|
|
21.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor:
Protocol IDs: CNR-ALPI, EORTC-08952, EU-94043
|
|
22.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 20 to 65
Sponsor: Other
Protocol IDs: YALE-HIC-7996, NCI-V95-0728
|
|
23.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: MRC-LU20, EU-95041
|
|
24.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 75
Sponsor:
Protocol IDs: BEL-GRECR-B, EU-96001
|
|
25.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Other
Protocol IDs: MRC-LU22, EORTC-08012, EU-97016, ISRCTN25582437, NCT00003159
|
